Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9P329 | IM / LL |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | C24B9 | IM / LL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 1 | UK042AA | IM / RL |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | X026330 | SC / LL |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | HR3649 | IM / RL |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Y013348 | SC / RL |
Onset upper respiratory illness 2/7/2025, congestion, postnasal drip 103.8 F, cough, vomiting. Diagnosed with RSV same day. Symptoms resolved. Thereafter, child presented with fever, rash on 2/13/2025 described as hives subjectively. Measles PCR Positive collected 2/15/2025.
Onset upper respiratory illness 2/7/2025, congestion, postnasal drip 103.8 F, cough, vomiting. Diagnosed with RSV same day. Symptoms resolved. Thereafter, child presented with fever, rash on 2/13/2025 described as hives subjectively per urgent care visit 2/14/25. Treated with amoxicillin. Measles throat swab PCR Positive collected 2/15/2025 attributed to vaccine-strain.
None documented
Unknown
NKA
RSV Rapid MultiPlex Positive collected 2/7/2025 (COVID, Flu A/B Negative); Measles PCR Positive collected 2/15/2025.